APOC-II-MIMETISCHE PEPTIDE

Patent europeic · EP3571216 · En vigur

Inscripziun en il register

Numer da publicaziun: EP3571216
Numer da la dumonda: EP18742118
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: En vigur
Scrittira da patent: Concedì
Annunzià: 19-01-2018
Publitgà: 27-11-2019
Concedì: 27-05-2026
La protecziun finescha il pli tard: 18-01-2038
Proxima taxa annuala scadenta: 31-01-2027
Classas IPC: C07K 14/00 (2006.01)
C07K 14/435 (2006.01)
A61K 38/00 (2006.01)
Prioritad: US 201762448358 P 19.01.2017
US 201762476535 P 24.03.2017
US 201762476531 P 24.03.2017
Dumonda PCT: PCT/US2018/014532 19.01.2018
Publicaziun PCT: WO2018/136803 26.07.2018
Lingua da l’annunzia: englais
Funtauna: Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

27-05-2026
Concedì
Specification status
Non-published patent application → Granted patent
Status of protective title
Initiated → Active
Published in Swissreg on 27.05.2026

Partidas

Possessur

The United States of America, as represented by the Secretary, Department of Health and Human Services

Office of Technology Transfer and Development 31 Center Drive, Room 4A29, MSC2479, Bethesda, MD 20892-2479, US

Novo Nordisk A/S

NOVO NORDISK A/S

Novo Allé, 2880 Bagsværd, DK

Inventur

REMALEY, Alan, Thomas

Rockville, MD 20852, US

GHOSH, Soumitra, Shanker

Waltham, MA 02451, US

DEVALARAJA, Madhav, N.

Waltham, MA 02451, US

LO, Chih-Hung

Waltham, MA 02451, US

SVIRIDOV, Denis, O.

Rockville, MD 20852, US

WOLSKA, Anna

Rockville, MD 20852, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.